Clinical Safety and Efficacy from the RESET-RA Study of a Novel Implantable Neuroimmune Modulation Device for the Treatment of Rheumatoid Arthritis

Presenting Author(s)

• RR

  Robert Richardson, MD, PhD, FAANS

  Director of Functional Neurosurgery
  Mass General